Literature DB >> 15618061

Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study.

Christa Meisinger1, Hannelore Loewel, Wilfried Mraz, Wolfgang Koenig.   

Abstract

AIMS: To investigate the association between apolipoprotein B (apoB), A-I (apoA-I), the apoB/apoA-I ratio, and the incidence of coronary events. METHODS AND
RESULTS: Analysis included 1414 men and 1436 women aged 35-64 years without a prior coronary event who participated in the population-based MONICA Augsburg survey 1984-85 (median followed-up period 13 years). Incidence of fatal and non-fatal myocardial infarction, and sudden cardiac death was assessed using data of the MONICA/KORA Augsburg coronary event registry. During follow-up, 114 incident coronary events occurred in men and 31 in women. In multivariable analysis, an increase of 1 standard deviation in the serum concentration of apoB was associated with an increased risk of coronary events in men [hazard ratio (HR)=1.49; 95% confidence interval (CI); 1.25-1.78] and in women (HR=1.73; 95% CI; 1.32-2.27). By contrast, elevated concentrations of apoA-I were not associated with a significantly decreased risk of coronary events in either sex (HR=0.91). Furthermore, the predictive power of the apoB/apoA-I ratio was similar to that of the total cholesterol/HDL cholesterol ratio in men and women.
CONCLUSION: ApoB and the apoB/apoA-I ratio were strong predictors of coronary events in middle-aged men and women, whereas apoA-I did not add significantly to the estimation of future coronary risk.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15618061     DOI: 10.1093/eurheartj/ehi003

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  27 in total

Review 1.  A clinical prescription for heart health in midlife women.

Authors:  Chrisandra Shufelt; Erika Dutra; Tina Torbati; Tina Ramineni
Journal:  Maturitas       Date:  2018-11-12       Impact factor: 4.342

2.  Evaluation of Lipid Profile and Apolipoproteins in Essential Hypertensive Patients.

Authors:  Parsuram Nayak; Suchismita Panda; Pravat Kumar Thatoi; Roma Rattan; Srikrushna Mohapatra; Pramila Kumari Mishra
Journal:  J Clin Diagn Res       Date:  2016-10-01

3.  Serum apolipoprotein B is inversely associated with eccentric left ventricular hypertrophy in peritoneal dialysis patients.

Authors:  Min Ye; Yanqiu Liu; Haoyu Wang; Na Tian; Wei Li; Wei He; Hong Lin; Rui Fan; Cuiling Li; Donghong Liu; Fengjuan Yao
Journal:  Int Urol Nephrol       Date:  2017-11-10       Impact factor: 2.370

4.  The ApoB/ApoA1 ratio is associated with metabolic syndrome and its components in a Chinese population.

Authors:  Li Zhong; Qifu Li; Yuanjuan Jiang; Dan Cheng; Zhoujun Liu; Bangqiong Wang; Rong Luo; Qingfeng Cheng; Hua Qing
Journal:  Inflammation       Date:  2010-12       Impact factor: 4.092

Review 5.  Progress of statistical analysis in biomedical research through the historical review of the development of the Framingham score.

Authors:  Aleksandra Ignjatović; Miodrag Stojanović; Zoran Milošević; Marija Anđelković Apostolović
Journal:  Ir J Med Sci       Date:  2017-12-02       Impact factor: 1.568

6.  Lipoprotein Biomarkers and Risk of Cardiovascular Disease: A Laboratory Medicine Best Practices (LMBP) Systematic Review.

Authors:  Paramjit K Sandhu; Salma M A Musaad; Alan T Remaley; Stephanie S Buehler; Sonya Strider; James H Derzon; Hubert W Vesper; Anne Ranne; Colleen S Shaw; Robert H Christenson
Journal:  J Appl Lab Med       Date:  2016-08-01

7.  The ratio of high-density lipoprotein cholesterol to apolipoprotein A-I predicts myocardial injury following elective percutaneous coronary intervention.

Authors:  Xiao-Lin Li; Jian-Jun Li; Yuan-Lin Guo; Cheng-Gang Zhu; Ping Qing; Na-Qiong Wu; Bo Xu; Run-Lin Gao
Journal:  Clin Cardiol       Date:  2014-08-11       Impact factor: 2.882

8.  Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population.

Authors:  Justo Sierra-Johnson; Rachel M Fisher; Abel Romero-Corral; Virend K Somers; Francisco Lopez-Jimenez; John Ohrvik; Göran Walldius; Mai-Lis Hellenius; Anders Hamsten
Journal:  Eur Heart J       Date:  2008-08-01       Impact factor: 29.983

9.  Apolipoproteins A-I, B, and C-III in young adult Cherokee with metabolic syndrome with or without type 2 diabetes.

Authors:  Wenyu Wang; Sohail Khan; Piers Blackett; Petar Alaupovic; Elisa Lee
Journal:  J Clin Lipidol       Date:  2012-07-02       Impact factor: 4.766

10.  Serum lipid profile constituents as markers of cardiovascular morbidity in patients on chronic hemodialysis.

Authors:  Dimitrios Kirmizis; Evangelia Koutoupa; Apostolos Tsiandoulas; Aphroditi Valtopoulou; Georgios Niavis; Phani Markou; Konstantinos Barboutis
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.